{"id":52296,"date":"2021-04-05T12:52:00","date_gmt":"2021-04-05T12:52:00","guid":{"rendered":"https:\/\/www.verificat.cat\/zf2001-work\/"},"modified":"2021-04-05T12:52:00","modified_gmt":"2021-04-05T12:52:00","slug":"zf2001-work","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/en\/zf2001-work\/","title":{"rendered":"ZF2001"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>The Chinese biopharmaceutical Group Anhui Zhifei Longcom Biologic Pharmacy has developed ZF2001, a <a href=\"https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/how-they-work.html\" target=\"_blank\" rel=\"noopener\">vaccine composed of protein subunits<\/a>, a molecule from the binding region with the host cell. This technique includes pieces of the viral Spike protein of the SARS-CoV-2 virus, instead of including the full pathogen. The organism recognizes this alien protein, producing T lymphocytes and antibodies that will provide a memory effect able to fight the virus causing covid-19 in case we get infected in the future.<\/p>\n<p><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04646590#wrapper\" target=\"_blank\" rel=\"noopener\">Phase III of the clinical trial<\/a> of ZF2001 started in December 2020 and has the support of 29,000 volunteers from <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/27\/\" target=\"_blank\" rel=\"noopener\">China, Ecuador, Indonesia, Pakistan, and Uzbekistan<\/a>.&nbsp;<\/p>\n<p>The vaccine has been approved by <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/27\/\" target=\"_blank\" rel=\"noopener\">China and Uzbekistan<\/a>, but it has yet to be determined if it will be administered in <a href=\"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(21)00127-4\/fulltext#seccestitle160\" target=\"_blank\" rel=\"noopener\">two or three doses<\/a>. Likewise, no data about its <a href=\"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(21)00127-4\/fulltext#seccestitle160\" target=\"_blank\" rel=\"noopener\">efficacy<\/a> have been published.<\/p>\n<p>Results from phases I and II <a href=\"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(21)00127-4\/fulltext#seccestitle160\" target=\"_blank\" rel=\"noopener\">discarded serious adverse reactions<\/a>.<\/p>\n<p>The manufacturer has not provided details about the temperature needed to preserve this vaccine.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Chinese biopharmaceutical Group Anhui Zhifei Longcom Biologic Pharmacy has  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[169],"tags":[208],"class_list":["post-52296","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-vaccines-en","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/comments?post=52296"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52296\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/media?parent=52296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/categories?post=52296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/tags?post=52296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}